Log in to save to my catalogue

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b0a4376e81f4df1be1193acb086c2c0

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

About this item

Full title

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2022-03, Vol.14 (3), p.e14455-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Psoriasis is a complex chronic inflammatory skin disease with unclear molecular mechanisms. We found that the Src homology‐2 domain‐containing protein tyrosine phosphatase‐2 (SHP2) was highly expressed in both psoriatic patients and imiquimod (IMQ)‐induced psoriasis‐like mice. Also, the SHP2 allosteric inhibitor SHP099 reduced pro‐inflammatory cyto...

Alternative Titles

Full title

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b0a4376e81f4df1be1193acb086c2c0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b0a4376e81f4df1be1193acb086c2c0

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202114455

How to access this item